Whalesbook
Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals.(Source : 201903 Annual Report Page No: 68)
Integrated nature of operationsIpca Laboratories is a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments.[1]IPCA is among India’s top 20 pharmaceutical companies.[2]Business segments FY22:API Business(25%)[3]Ipca produces over 80 APIs, nearly 79% of the APIs and Intermediates business is from exports making them one of India’s top exporters of APIs, serving over 100 countries around the globe. The core strategic focus has been on backward integration, resulting in superior supply chain reliability and cost competitiveness[4][1][5]
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Sun Pharma.Inds. | 1818.60 | 37.82 | 436584.71 | 0.88 | 3124.95 | 2.56 | 14478.31 | 8.93 | 20.21 | 54964.01 | 30.12 | 11543.96 | 3117.95 | 5.61 | 12.97 | 0.07 |
| 2. | Divi's Lab. | 6418.20 | 68.57 | 170398.88 | 0.46 | 689.00 | 35.10 | 2715.00 | 16.12 | 20.44 | 10029.00 | 32.37 | 2485.00 | 689.00 | 11.05 | 13.53 | 0.01 |
| 3. | Torrent Pharma. | 3803.20 | 59.46 | 128813.91 | 0.84 | 591.00 | 32.49 | 3302.00 | 14.30 | 27.05 | 12248.00 | 32.60 | 2166.53 | 600.17 | 15.23 | 13.26 | 0.33 |
| 4. | Cipla | 1521.20 | 22.58 | 122870.01 | 0.85 | 1353.37 | 3.73 | 7589.44 | 7.64 | 22.72 | 28349.57 | 25.40 | 5441.14 | 1351.17 | 3.73 | 14.72 | 0.01 |
| 5. | Dr Reddy's Labs | 1279.50 | 18.51 | 106802.30 | 0.63 | 1336.80 | 7.28 | 8828.30 | 9.83 | 22.69 | 34310.00 | 24.64 | 5772.20 | 1347.10 | 2.96 | 12.95 | 0.16 |
| 6. | Lupin | 2091.95 | 22.09 | 95529.40 | 0.57 | 1484.83 | 73.34 | 7047.51 | 24.23 | 21.30 | 24750.69 | 27.25 | 4324.63 | 1477.92 | 4.87 | 12.41 | 0.32 |
| 7. | Zydus Lifesci. | 935.40 | 18.69 | 94027.59 | 1.18 | 1238.60 | 40.92 | 6123.20 | 16.92 | 24.31 | 24493.90 | 31.10 | 5029.35 | 1283.60 | 3.72 | 14.64 | 0.38 |
| 8. | Ipca Labs. | 1457.00 | 38.11 | 36921.23 | 0.27 | 304.74 | 24.83 | 1930.32 | 6.59 | 17.58 | 6978.34 | 23.52 | 968.63 | 304.74 | 4.99 | 9.41 | 0.11 |
| – | Median: 148 Co. | 411.62 | 31.73 | 1717.18 | 0.12 | 12.57 | 12.32 | 152.64 | 10.54 | 14.98 | 582.87 | 15.93 | 44.55 | 13.49 | 3.19 | 8.6 | 0.22 |
Standalone figures in ₹ crores
| Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,495 | 1,440 | 1,402 | 1,486 | 1,663 | 1,507 | 1,511 | 1,566 | 1,811 | 1,663 | 1,638 | 1,747 | 1,930 |
Expenses | 1,224 | 1,229 | 1,226 | 1,189 | 1,314 | 1,234 | 1,218 | 1,213 | 1,409 | 1,252 | 1,280 | 1,340 | 1,466 |
Operating Profit | 270 | 211 | 176 | 298 | 348 | 273 | 292 | 353 | 402 | 411 | 359 | 407 | 465 |
Other Income | 36 | 24 | 33 | 43 | -3 | 17 | -79 | 15 | 17 | 17 | -260 | 25 | 22 |
Profit before tax | 240 | 166 | 132 | 250 | 245 | 200 | 127 | 288 | 339 | 356 | 17 | 357 | 408 |
Tax % | 31% | 31% | 36% | 33% | 34% | 32% | 49% | 29% | 28% | 25% | 479% | 27% | 25% |
Net Profit | 166 | 115 | 85 | 167 | 162 | 137 | 65 | 204 | 244 | 268 | -65 | 262 | 305 |
EPS in Rs | 6.53 | 4.54 | 3.34 | 6.57 | 6.39 | 5.40 | 2.55 | 8.05 | 9.62 | 10.55 | -2.56 | 10.33 | 12.01 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 3,235 | 3,088 | 2,804 | 3,102 | 3,193 | 3,606 | 4,338 | 5,114 | 5,405 | 5,775 | 6,124 | 6,678 | 6,978 |
Expenses | 2,498 | 2,556 | 2,526 | 2,666 | 2,748 | 2,909 | 3,419 | 3,596 | 4,164 | 4,858 | 4,909 | 5,153 | 5,337 |
Operating Profit | 737 | 532 | 277 | 436 | 446 | 697 | 918 | 1,518 | 1,241 | 917 | 1,215 | 1,525 | 1,641 |
Other Income | 21 | 32 | 26 | 19 | 39 | 54 | 64 | 61 | 53 | 108 | -23 | -210 | -196 |
Interest | 28 | 29 | 31 | 26 | 27 | 21 | 19 | 11 | 10 | 46 | 123 | 63 | 50 |
Depreciation | 101 | 177 | 161 | 171 | 174 | 172 | 179 | 188 | 210 | 229 | 246 | 252 | 258 |
Profit before tax | 629 | 358 | 111 | 258 | 283 | 557 | 785 | 1,380 | 1,074 | 750 | 822 | 1,000 | 1,138 |
Net Profit | 477 | 256 | 93 | 188 | 233 | 455 | 652 | 1,141 | 860 | 506 | 530 | 651 | 769 |
EPS in Rs | 18.91 | 10.15 | 3.67 | 7.46 | 9.24 | 18.00 | 25.82 | 44.97 | 33.91 | 19.93 | 20.91 | 25.65 | 30.33 |
Dividend Payout % | 13% | 5% | 0% | 7% | 5% | 8% | 10% | 9% | 12% | 20% | 19% | 16% | – |
Standalone figures in ₹ crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
Reserves | 1,956 | 2,208 | 2,258 | 2,450 | 2,670 | 3,111 | 3,652 | 4,727 | 5,450 | 5,852 | 6,323 | 6,866 | 7,382 |
Borrowings | 595 | 929 | 865 | 716 | 628 | 444 | 474 | 236 | 776 | 1,440 | 1,152 | 906 | 780 |
Other Liabilities | 641 | 662 | 756 | 777 | 785 | 877 | 1,033 | 1,021 | 1,186 | 1,129 | 1,159 | 1,273 | 1,374 |
Total Liabilities | 3,217 | 3,824 | 3,905 | 3,968 | 4,108 | 4,458 | 5,185 | 6,010 | 7,438 | 8,447 | 8,659 | 9,071 | 9,562 |
Fixed Assets | 1,306 | 1,753 | 1,977 | 1,946 | 1,855 | 1,740 | 1,841 | 1,869 | 2,153 | 2,479 | 2,524 | 2,543 | 2,695 |
Gross Block | 1,851.29 | 2,465.90 | 2,137.32 | 2,276.99 | 2,358.72 | 2,412.97 | 2,688.79 | 2,899.27 | 3,364.68 | 3,889.09 | 4,165.82 | – | – |
Accumulated Depreciation | 545.18 | 712.94 | 160.74 | 331.02 | 504.11 | 672.87 | 847.82 | 1,030.67 | 1,211.59 | 1,410.43 | 1,642.12 | – | – |
CWIP | 165 | 267 | 129 | 95 | 73 | 66 | 84 | 182 | 297 | 123 | 175 | 484 | 546 |
Investments | 29 | 82 | 97 | 212 | 216 | 322 | 649 | 868 | 1,339 | 1,057 | 2,654 | 2,693 | 2,850 |
Other Assets | 1,717 | 1,722 | 1,702 | 1,716 | 1,964 | 2,329 | 2,611 | 3,092 | 3,650 | 4,789 | 3,306 | 3,351 | 3,471 |
Total Assets | 3,217 | 3,824 | 3,905 | 3,968 | 4,108 | 4,458 | 5,185 | 6,010 | 7,438 | 8,447 | 8,659 | 9,071 | 9,562 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | 515 | 455 | 696 | 271 | 324 | 496 | 561 | 1,096 | 832 | 762 | 831 | 1,374 |
Cash from Investing Activity | -362 | -686 | -214 | -146 | -119 | -123 | -499 | -560 | -812 | -710 | -1,355 | -739 |
Cash from Financing Activity | -138 | 255 | -414 | -156 | -130 | -223 | -139 | -307 | 426 | 506 | -465 | -428 |
Net Cash Flow | 14 | 25 | 68 | -31 | 74 | 150 | -76 | 229 | 446 | 559 | -990 | 207 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 51 | 42 | 57 | 59 | 68 | 64 | 71 | 55 | 56 | 59 | 61 | 63 |
Inventory Days | 271 | 293 | 290 | 288 | 286 | 332 | 312 | 350 | 364 | 293 | 309 | 297 |
Days Payable | 109 | 97 | 145 | 128 | 136 | 146 | 133 | 121 | 101 | 80 | 78 | 93 |
Cash Conversion Cycle | 213 | 238 | 203 | 219 | 218 | 250 | 250 | 284 | 319 | 272 | 293 | 268 |
Working Capital Days | 83 | 69 | 62 | 75 | 82 | 93 | 91 | 108 | 105 | 74 | 87 | 120 |
ROCE % | 27% | 13% | 4% | 9% | 9% | 17% | 20% | 30% | 19% | 11% | 14% | 18% |
Direct from BSE filings, auto-summarised
External media mentions & references
Editorial & research coverage
Nov 2025
Aug 2025
Jun 2025
Feb 2025
Nov 2024
Aug 2024
Jun 2024
Feb 2024
Nov 2023
Aug 2023
Apr 2023
Feb 2023
Nov 2022
Aug 2022
May 2022
Feb 2022
Nov 2021
Aug 2021
Jun 2021
Jun 2021
Mar 2021
Nov 2020
Aug 2020
Jun 2020
Feb 2020
Nov 2019
Aug 2019
May 2019
Feb 2019
Nov 2018
